We are live on
!
Find out more
PP
PDT Partners Portfolio holdings
AUM
$1.69B
1-Year Est. Return
74.01%
This Fund
S&P 500
This Quarter
Est. Return
+11.11%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$2.63B
AUM Growth
-$329M
(-11%)
Cap. Flow
-$517M
Cap. Flow
% of AUM
-19.64%
Top 10 Holdings %
Top 10 Hldgs %
12.51%
Holding
623
New
72
Increased
126
Reduced
271
Closed
121
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRO
Marathon Oil Corporation
MRO
|
+$9.89M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$9.66M |
| 3 |
General Motors
GM
|
+$9.56M |
| 4 |
F5
FFIV
|
+$9.36M |
| 5 |
Expedia Group
EXPE
|
+$8.91M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$30.7M |
| 2 |
Masco
MAS
|
+$29.1M |
| 3 |
Western Union
WU
|
+$25.9M |
| 4 |
WLL
Whiting Petroleum Corporation
WLL
|
+$24.1M |
| 5 |
Corning
GLW
|
+$20.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.49% |
| 2 | Healthcare | 22.21% |
| 3 | Consumer Discretionary | 11.9% |
| 4 | Industrials | 10.14% |
| 5 | Financials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRGA
476
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $185K | 0.01% |
1,343
-180
| -12% | -$24.8K |
|
|
VOXX
477
DELISTED
VOXX International Corporation Class A
VOXX
| $178K | 0.01% |
32,934
-2,200
| -6% | -$11.6K |
|
|
MTVA
478
MetaVia Inc
MTVA
$7.64M
| – | – |
0
| – | – |
|
479
Simply Good Foods
SMPL
$904M
| $176K | 0.01% |
12,160
-76,240
| -86% | -$1.02M |
|
480
Adtran
ADTN
$798M
| $168K | 0.01% |
+11,319
| New | +$169K |
|
481
Standard BioTools
LAB
$326M
| $165K | 0.01% |
27,601
-7,717
| -22% | -$44K |
|
|
WAAS
482
DELISTED
AquaVenture Holdings Limited
WAAS
| $165K | 0.01% |
10,612
-1,106
| -9% | -$15.9K |
|
483
Xenon Pharmaceuticals
XENE
$6.32B
| $164K | 0.01% |
+17,837
| New | +$111K |
|
|
RARX
484
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $164K | 0.01% |
16,434
-50,638
| -75% | -$350K |
|
485
inTEST
INTT
$173M
| $158K | 0.01% |
21,639
-1,361
| -6% | -$9.66K |
|
|
SVM
486
Silvercorp Metals
SVM
$2.13B
| $156K | 0.01% |
59,241
-2,896
| -5% | -$8.11K |
|
|
GV
487
DELISTED
Goldfield Corporation
GV
| $149K | 0.01% |
34,988
-31,900
| -48% | -$137K |
|
|
FOMX
488
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $148K | 0.01% |
29,600
-5,500
| -16% | -$28.3K |
|
489
Harvard Bioscience
HBIO
$27.1M
| $147K | 0.01% |
2,750
-300
| -10% | -$15.4K |
|
490
Ameresco
AMRC
$1.15B
| $143K | 0.01% |
11,942
-14,380
| -55% | -$171K |
|
|
MACK
491
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $142K | 0.01% |
36,859
-30,631
| -45% | -$203K |
|
|
IVAC
492
DELISTED
Intevac Inc
IVAC
| $130K | ﹤0.01% |
26,811
-1,845
| -6% | -$9.79K |
|
493
Riverview Bancorp
RVSB
$107M
| $126K | ﹤0.01% |
14,900
-7,800
| -34% | -$69.5K |
|
494
Radiant Logistics
RLGT
$416M
| $124K | ﹤0.01% |
31,700
-8,600
| -21% | -$33.6K |
|
|
KDNY
495
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $120K | ﹤0.01% |
3,427
-15,533
| -82% | -$596K |
|
496
Genie Energy
GNE
$378M
| $110K | ﹤0.01% |
22,273
-1,600
| -7% | -$7.74K |
|
497
Green Brick Partners
GRBK
$3.13B
| $103K | ﹤0.01% |
10,500
-3,200
| -23% | -$35.1K |
|
|
JE
498
DELISTED
Just Energy Group Inc
JE
| $98K | ﹤0.01% |
822
-829
| -50% | -$108K |
|
499
AudioCodes
AUDC
$244M
| $92K | ﹤0.01% |
11,804
-8,800
| -43% | -$63.7K |
|
500
LifeVantage
LFVN
$82.4M
| $68K | ﹤0.01% |
10,600
+300
| +3% | +$1.37K |
|
Similar funds
ISS
GAM
BCM
FACM
TCBWMS
WAS
SGI
AAM
PDT Partners's Q2 2018 Portfolio in Review
As of Q2 2018, PDT Partners held 623 positions worth $2.63B, down 11% from $2.96B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
PDT Partners withdrew a net $517M in Q2 2018, closing 121 positions and reducing 271 holdings. Its most notable exit was Lowe's Companies, an estimated $30.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, PDT Partners opened a new position in Marathon Oil Corporation worth $10.5M.
- PDT Partners's largest Q2 2018 buy was Marathon Oil Corporation: 501,684 shares worth $10.5M.
- PDT Partners added most to Ferrari in Q2 2018, an estimated $8.31M increase.
- PDT Partners's biggest Q2 2018 reduction was Whiting Petroleum Corporation, cutting an estimated $24.1M.
- PDT Partners fully exited Lowe's Companies in Q2 2018, selling an estimated $30.7M.
- PDT Partners's ten largest holdings make up 13% of its $2.63B portfolio in Q2 2018.
- PDT Partners opened 72 new positions and closed 121 in Q2 2018.
- PDT Partners's portfolio value fell 11% quarter-over-quarter to $2.63B.
Based on PDT Partners's 13F filing for Q2 2018, filed 14 Aug 2018.